• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂在治疗恶性骨与软组织肿瘤中的毒性作用

[Toxic effects of cisplatin in the treatment of malignant bone and soft tissue tumors].

作者信息

Umeda T, Takada N, Hodaka E, Endoh F, Ishii T

出版信息

Gan To Kagaku Ryoho. 1986 May;13(5):1857-61.

PMID:3707148
Abstract

A total of 31 patients with malignant bone and soft tissue tumors were evaluated for toxic effects after receiving cisplatin (104 courses) at doses of 2.0-3.0 mg/kg with aggressive hydration. Nausea was common and in 86% of cisplatin courses severe vomiting was observed. Nephrotoxicity was observed in less than 10% of all courses but ototoxicity, especially tinnitis, developed in 5 of 6 patients whose total doses of cisplatin were over 500mg, and one of them showed hearing disorder in the upper frequency above 5,000 Hz. There were no other toxic effects such as severe myelosuppression, allergic reaction or peripheral neuropathy.

摘要

共有31例恶性骨与软组织肿瘤患者接受了剂量为2.0 - 3.0mg/kg的顺铂治疗(共104个疗程),同时进行积极水化,并对其毒性作用进行评估。恶心很常见,在86%的顺铂疗程中观察到严重呕吐。在所有疗程中,肾毒性的发生率低于10%,但在6例顺铂总剂量超过500mg的患者中,有5例出现耳毒性,尤其是耳鸣,其中1例在5000Hz以上的高频出现听力障碍。未观察到其他毒性作用,如严重骨髓抑制、过敏反应或周围神经病变。

相似文献

1
[Toxic effects of cisplatin in the treatment of malignant bone and soft tissue tumors].顺铂在治疗恶性骨与软组织肿瘤中的毒性作用
Gan To Kagaku Ryoho. 1986 May;13(5):1857-61.
2
[Chemotherapy using cisplatin in bone and soft tissue sarcoma].
Gan To Kagaku Ryoho. 1987 Jan;14(1):100-4.
3
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.顺二氯二氨铂(II)治疗晚期软组织和骨肉瘤:西南肿瘤协作组研究
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2027-9.
4
[Toxic effects of ifosfamide in the treatment of bone and soft tissue sarcomas].异环磷酰胺治疗骨肉瘤和软组织肉瘤的毒性作用
Gan To Kagaku Ryoho. 1993 Mar;20(4):509-14.
5
Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.通过动脉内注射(99m)锝-大颗粒白蛋白对骨与软组织肿瘤患者进行动脉内化疗时肌皮不良副作用的预测。
J Nucl Med. 2002 Nov;43(11):1452-6.
6
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.儿童顺铂持续或重复长时间输注:一项关于耳毒性、铂浓度及标准血清参数的前瞻性研究。
Pediatr Blood Cancer. 2006 Aug;47(2):183-93. doi: 10.1002/pbc.20673.
7
Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.接受顺铂治疗患者的耳毒性:药物剂量和给药方法的重要性。
Cancer Treat Rep. 1982 Jan;66(1):19-23.
8
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.异环磷酰胺和顺铂治疗转移性肉瘤的II期试验:西南肿瘤协作组研究
Cancer Chemother Pharmacol. 1993;31 Suppl 2:S213-6.
9
Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.雷莫司琼联合地塞米松预防顺铂所致恶心和呕吐的II期试验
J Med Assoc Thai. 2005 Dec;88(12):1790-6.
10
[Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].盐酸昂丹司琼与地塞米松联合使用对接受顺铂治疗的肺癌患者恶心呕吐的影响
Gan To Kagaku Ryoho. 1998 Dec;25(14):2275-81.

引用本文的文献

1
Platinum-induced hearing loss after treatment for childhood cancer.儿童癌症治疗后铂诱导的听力损失。
Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2.